Previous 10 | Next 10 |
home / stock / vph:cc / vph:cc news
Leon's Furniture Limited (LNF:CA) is expected to report for Q2 2023 Dollarama Inc. (DOL:CA) is expected to report $0.77 for Q2 2024 Source Energy Services Ltd. (SHLE:CA) is expected to report for Q1 2024 Orsu Metals Corporation (OSU.H:CA) is expected to report for quarter end 2023-06-...
Valeo Pharma Inc. Class A shares (VPH:CA) is expected to report $-0.06 for Q3 2023
VALEO PHARMA TO HOST THIRD QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , Sept. 7, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, annou...
2023-09-02 20:00:00 ET Valeo Pharma is now ranked among the top 10 undervalued stocks in the Drug Manufacturers industry on the Toronto Stock Exchange or TSX Venture Exchange. A stock is considered undervalued if it trades at a discount to its valuation – a calculation used t...
VALEO PHARMA CLOSES $4.5 MILLION FINANCING Canada NewsWire $3.92 million raised from non-brokered private placement offering, and $0.58 million from insider loan Investissement Québec and insiders each invest $2.0 million Proceeds fro...
VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS Canada NewsWire MONTREAL , June 22, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, today announced that Ms. Tamara...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share news the company has once again seen record numbers as it unveils its second-quarter financials. The numbers include the 6th consecutive quarter of revenue growth at $13.6 million, up 184% over 2Q 2...
VALEO PHARMA TO HOST SECOND QUARTER 2023 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL , June 7, 2023 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE:VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical company, announ...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to share guidance for the company’s second-quarter that reveal it is heading for the sixth straight quarter of record revenue. The company said it expects 2Q revenue to exceed $13.5 million while ...
VALEO PHARMA PROVIDING GUIDANCE OF RECORD REVENUES FOR THE SECOND QUARTER 2023 Canada NewsWire Q2-23 revenues to exceed $13.5 million Q2-23 adjusted EBITDA loss to decrease below $2.0 million Q2-23 operating expenses to remain in line with pri...
News, Short Squeeze, Breakout and More Instantly...
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE Canada NewsWire MONTREAL , June 18, 2024 /CNW/ - Valeo Pharma Inc . (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) (" Valeo " or the " Company "), a Canadian pharmaceutical compan...
--News Direct-- Valeo Pharma CEO Steve Saviuk joined Steve Darling from Proactive to discuss the company's financial results for the second quarter, which saw record-breaking revenue for the period. The company reported revenues of $14.1 million for Q2, an increase from the $13.6 million ...
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES Canada NewsWire Record Q2-24 revenues of $14.1 million , up 4% over Q2-23 outpacing revenue softness in several non-core brands Q2-24 adjusted EBITDA loss of $2.5 million compared to $1.7 million fo...